This ticker has not been starred yet AGEN Agenus Inc
Biological Products (no Diagnostic Substances)
Book value per $ invested $ -0.23
Leverage 222.58%
Market Cap $ 1.3B
PE 0.00
Dividend Yield 0.00%
Profit $ -233.0m
Margin -141.64%

Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company is headquartered in Lexington, Massachusetts.

Subscribe Now For Access - Only $1.99 Per Month